Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
A clinical trial sponsored by Istituto Oncologico Veneto IRCCS is evaluating financial toxicity using the PROFFIT questionnaire in patients …
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer [Phase 1]
An exploratory Phase 1 study evaluating nimotuzumab in bladder-sparing chemoradiotherapy for muscle-invasive bladder cancer; the trial is no…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors [Phase 1]
This Phase 1 trial assesses Autogene Cevumeran (RO7198457) as a single agent and in combination with atezolizumab across multiple locally ad…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale
An ongoing clinical trial aims to stage bladder cancer and predict the efficacy of a new adjuvant chemotherapy using Ultrasound-MRI-Patholog…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer [Phase 2]
A Phase 2 clinical trial is evaluating atezolizumab with etoposide and platinum chemotherapy for small cell bladder cancer and is currently …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Chemoablation for Low-Grade Bladder Cancer [Phase 2]
A Phase 2 clinical trial evaluating chemoablation for low-grade bladder cancer is currently recruiting.
-
FDA approval · 2025-06-12FDA Approved: ZUSDURI — Original Application (UroGen Pharma, Inc)
FDA approves ZUSDURI (mitomycin) from UroGen Pharma under an original NDA, marking its first approval for use in bladder cancer.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This update covers a completed Phase 1/2 clinical trial evaluating Tinengotinib (TT-00420) as both monotherapy and in combination therapy fo…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Basal Tumours in Bladder Cancer, Response to chemoTherapy
A completed clinical trial update focusing on basal tumors in bladder cancer and their response to chemotherapy.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors [Phase 2]
This is a Phase II multicohort trial assessing sEphB4-HSA in combination with pembrolizumab for solid tumors; the study is currently active …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
A clinical trial is evaluating a deep learning radiomics model to predict outcomes after cystectomy in patients with muscle-invasive bladder…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]
This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancr…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Selecting Hypoxic Tumours for Treatment Modification
A University of Manchester-sponsored clinical trial is exploring selecting hypoxic bladder cancer and prostate cancer tumors for treatment m…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Quality of Life in Patients With Bladder Cancer
An ongoing study evaluating quality of life in patients with bladder cancer; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder Cancer
Ongoing clinical trial evaluating a deep learning system that uses whole-slide images and CT radiomics to prognosticate outcomes in bladder …
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
A clinical trial evaluating urinary microbiome differences among bladder cancer patients, individuals with benign urinary conditions, and he…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: The Effect of Perioperative Heated Sock Application on Hypothermia and Vital Signs in Bladder Tumor Surgery [NA]
Clinical trial investigating the use of heated socks to reduce perioperative hypothermia and monitor vital signs during bladder cancer surge…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
This clinical trial update describes a study evaluating the microvascular environment of bladder cancer using super-resolution ultrasound lo…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study evaluating MNPR-101-DFO*-89Zr as a diagnostic imaging agent for adults with various…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of MNPR-101-PCTA-177Lu in solid tumors is currently recruiting across multiple cancer indications.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery [Phase 3]
Phase 3 trial evaluating nutrition therapy to boost immune function in bladder cancer patients eligible for surgical removal; results have b…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating APR-246 in combination with pembrolizumab in solid tumors has completed enrollment with results posted…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer [Phase 1]
This Phase 1 trial investigates adjuvant concurrent immunotherapy and radiotherapy for bladder cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI's Pan-tumor Priority Study is an observational cancer study that is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study of Disitamab Vedotin combined with Ivonescimab in cisplatin-ineligible muscle-invasive bladder c…